Mode
Text Size
Log in / Sign up

Observational study finds one third of U.S. adults report hypertension, with 75% of those using medication

Observational study finds one third of U.S. adults report hypertension, with 75% of those using medi…
Photo by KOBU Agency / Unsplash
Key Takeaway
Note: Observational, self-reported data on hypertension and medication prevalence show association, not causation.

An observational study examined the prevalence of self-reported hypertension and antihypertensive medication use among U.S. adults. The study design was observational, and the specific sample size, follow-up duration, and comparator group were not reported. The main findings were that approximately one third of the studied population reported having hypertension. Among those reporting hypertension, an estimated 75% reported using antihypertensive medication. No specific effect sizes, absolute numbers, or statistical measures (like p-values or confidence intervals) were provided for these prevalence estimates. Safety and tolerability data for the medications were not reported in this analysis. A key limitation is the reliance on self-reported data for both hypertension diagnosis and medication use, which may be subject to recall bias or misclassification. The study's funding sources and potential conflicts of interest were not reported. Given the observational nature and self-reported data, these results show an association but cannot establish causation. They should not be interpreted as evidence of treatment efficacy or specific clinical outcomes. The practice relevance of this descriptive analysis was not explicitly stated.

Study Details

EvidenceLevel 5
PublishedApr 2020
View Original Abstract ↓
Analysis of 2017 Behavioral Risk Factor Surveillance System data found that approximately one third of U.S. adults reported having hypertension, and an estimated 75% of those reporting having hypertension reported using antihypertensive medication.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.